loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 10812 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Grace

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    EXCIPIENTS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Aspen API. More than just an API.

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Grace (1)

    filter

    01 MACA (5-METHANESULFONYLAMINOINDOLE-2-CARBOXYLIC ACID) (1)

    filter

    01 U.S.A (1)

    filter

    01 Inactive (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    WR GRACE AND CO

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      MACA (5-METHANESULFONYLAMINOINDOLE-2-CARBOXYLIC ACID)

      PDF Supplier PDF
      URL Supplier Web Content
      10812
      Inactive
      1994-03-15
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 10812 of Wr Grace And Co

      Looking for Drug Master Files (DMF) for 10812 of Wr Grace And Co 1

      20

      Wr Grace And Co, based in U.S.A, is a pharmaceutical company.

      One of their notable products is MACA (5-METHANESULFONYLAMINOINDOLE-2-CARBOXYLIC ACID), with a corresponding US DMF Number 10812.

      Remarkably, this DMF maintains an Inactive status since its submission on March 15, 1994, highlighting commitment to regulatory compliance.

      Post Enquiry
      POST ENQUIRY